-
公开(公告)号:US20240000940A1
公开(公告)日:2024-01-04
申请号:US18039728
申请日:2021-11-30
申请人: NANOBIOTIX S.A.
CPC分类号: A61K41/0038 , A61P35/00 , A61N5/1001 , A61K33/42 , B82Y5/00 , A61N2005/1098
摘要: The invention concerns a particle and a composition comprising particles and their use in oncology. Specifically, the particles are porous, high-Z and carbon-free particles having internal pores, of longest dimension of at least 0.5 nm, and are for use in altering or destroying target cells in a mammal when said cells are exposed to ionizing radiation.
The present invention also provides a porous, high-Z and carbon-free particle wherein at least part of the porous structure of the particle is occupied by at least one therapeutic agent which is preferably for use in oncology.-
公开(公告)号:US20220212008A1
公开(公告)日:2022-07-07
申请号:US17697976
申请日:2022-03-18
申请人: NANOBIOTIX S.A.
发明人: MARIE-EDITH MEYRE , AGNÈS POTTIER , LAURENT LEVY
摘要: The present invention relates to the medical field, in particular to the treatment of neurological disorders. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in prevention or treatment of a neurological disease or at least one symptom thereof in a subject when the nanoparticle or nanoparticles' aggregate is exposed to an electric field, wherein the nanoparticle's or nanoparticles' aggregate's material is selected from a conductor material, a semiconductor material, an insulator material with a dielectric constant εijk equal to or above 200, and an insulator material with a dielectric constant εijk equal to or below 100. It further relates to compositions and kits comprising such nanoparticles and/or nanoparticles' aggregates as well as to uses thereof.
-